Guido Lammering1, Marc Vooijs1, Jan Theys1, Barry Jutten1, Roger Habets1, Kim Paesmans1, Arjan J Groot1, Philippe Lambin1, Brad G Wouters1,2,3. 1. Department of Radiation Oncology (MAASTRO lab), Maastricht University Medical Centre, The Netherlands. 2. Ontario Cancer Institute and Campbell Family Institute for Cancer Research, University Health Network, Toronto, Canada. 3. Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Canada.
Abstract
BACKGROUND AND PURPOSE: Hypoxia is a hallmark of solid cancers and associated with metastases and treatment failure. During tumor progression epithelial cells often acquire mesenchymal features, a phenomenon known as epithelial-to-mesenchymal transition (EMT). Intratumoral hypoxia has been linked to EMT induction. We hypothesized that signals from the tumor microenvironment such as growth factors and tumor oxygenation collaborate to promote EMT and thereby contribute to radioresistance. MATERIALS AND METHODS: Gene expression changes under hypoxia were analyzed using microarray and validated by qRT-PCR. Conversion of epithelial phenotype upon hypoxic exposure, TGFβ addition or oncogene activation was investigated by Western blot and immunofluorescence. Cell survival following ionizing radiation was assayed using clonogenic survival. RESULTS: Upon hypoxia, TGFβ addition or EGFRvIII expression, MCF7, A549 and NMuMG epithelial cells acquired a spindle shape and lost cell-cell contacts. Expression of epithelial markers such as E-cadherin decreased, whereas mesenchymal markers such as vimentin and N-cadherin increased. Combining hypoxia with TGFβ or EGFRvIII expression, lead to more rapid and pronounced EMT-like phenotype. Interestingly, E-cadherin expression and the mesenchymal appearance were reversible upon reoxygenation. Mesenchymal conversion and E-cadherin loss were associated with radioresistance. CONCLUSIONS: Our findings describe a mechanism by which the tumor microenvironment may contribute to tumor radioresistance via E-cadherin loss and EMT.
BACKGROUND AND PURPOSE:Hypoxia is a hallmark of solid cancers and associated with metastases and treatment failure. During tumor progression epithelial cells often acquire mesenchymal features, a phenomenon known as epithelial-to-mesenchymal transition (EMT). Intratumoral hypoxia has been linked to EMT induction. We hypothesized that signals from the tumor microenvironment such as growth factors and tumor oxygenation collaborate to promote EMT and thereby contribute to radioresistance. MATERIALS AND METHODS: Gene expression changes under hypoxia were analyzed using microarray and validated by qRT-PCR. Conversion of epithelial phenotype upon hypoxic exposure, TGFβ addition or oncogene activation was investigated by Western blot and immunofluorescence. Cell survival following ionizing radiation was assayed using clonogenic survival. RESULTS: Upon hypoxia, TGFβ addition or EGFRvIII expression, MCF7, A549 and NMuMG epithelial cells acquired a spindle shape and lost cell-cell contacts. Expression of epithelial markers such as E-cadherin decreased, whereas mesenchymal markers such as vimentin and N-cadherin increased. Combining hypoxia with TGFβ or EGFRvIII expression, lead to more rapid and pronounced EMT-like phenotype. Interestingly, E-cadherin expression and the mesenchymal appearance were reversible upon reoxygenation. Mesenchymal conversion and E-cadherin loss were associated with radioresistance. CONCLUSIONS: Our findings describe a mechanism by which the tumor microenvironment may contribute to tumor radioresistance via E-cadherin loss and EMT.
Authors: Xiaomeng Zhang; Qi Wang; Ming-Tat Ling; Yong Chuan Wong; Steve C L Leung; Xianghong Wang Journal: Int J Cancer Date: 2007-05-01 Impact factor: 7.396
Authors: Miguel A Esteban; Maxine G B Tran; Sarah K Harten; Peter Hill; Maria C Castellanos; Ashish Chandra; Raju Raval; Tim S O'brien; Patrick H Maxwell Journal: Cancer Res Date: 2006-04-01 Impact factor: 12.701
Authors: C J Wikstrand; L P Hale; S K Batra; M L Hill; P A Humphrey; S N Kurpad; R E McLendon; D Moscatello; C N Pegram; C J Reist Journal: Cancer Res Date: 1995-07-15 Impact factor: 12.701
Authors: Karen A Simon; Kyeng Min Park; Bobak Mosadegh; Anand Bala Subramaniam; Aaron D Mazzeo; Philip M Ngo; George M Whitesides Journal: Biomaterials Date: 2013-10-02 Impact factor: 12.479
Authors: Hanneke Stegeman; Johannes H Kaanders; Albert J van der Kogel; Mari Iida; Deric L Wheeler; Paul N Span; Johan Bussink Journal: Radiother Oncol Date: 2013-02-28 Impact factor: 6.280